ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Co-stimulation"

  • 2016 American Transplant Congress

    Costimulation Blockade by Anti CD40 Antibody Prevents Humoral and Cellular Rejection of Heterotopic Pig Cardiac Xenograft.

    A. Singh,1 J. Chan,1 P. Corcoran,1 B. Lewis,2 M. Thomas,2 D. Ayares,3 K. Horvath,1 M. Mohiuddin.1

    1CSRP/NHLBI, NIH, Bethesda, MD; 2DVR/ORS, NIH, Bethesda, MD; 3Revivicor Inc., Blacksburg, VA.

    BackgroundXenotransplantation (XTx) involves the participation of innate immune system with natural antibody producing B cells, NK cells, macrophages and complement as well as adaptive immune…
  • 2016 American Transplant Congress

    2B4 Over-Expression Impairs Donor-Reactive CD8+ T Cell Proliferation and Accumulation Following Transplantation.

    S. Laurie, D. Liu, M. Ford.

    Emory Transplant Center, Emory University School of Medicine, Atlanta, GA.

    T cell function is tightly regulated by a fine balance of coinhibitory signals, including those transduced by 2B4 (SLAMf4, CD244), an immunoglobulin-superfamily member constitutively expressed…
  • 2016 American Transplant Congress

    Imaging Cell Biology In Vivo with Intravital-Microscopy.

    T. Ueno,1 M. Yeung,1 N. Igarashi,3 T. Yokoyama,2 Y. Kihara,2 O. Konno,2 Y. Nakamura,2 H. Iwamoto,2 T. Ikeda,3 M. McGrath,1 M. Sayegh,1 A. Chandraker.1

    1Renal Division, Transplantation Research Center, Brigham and Women's Hospital, Boston, MA; 2Transplant Surgery, Tokyo Medical Univ., Hachioji, Tokyo, Japan; 3Intensive Care Medicine, Tokyo Medical Univ., Hachioji, Tokyo, Japan.

    Background: Despite current immunosuppressive therapy, many recipients endure multiple episodes of acute rejection. The interplay between dendritic cells (DCs) and T cells plays a central…
  • 2016 American Transplant Congress

    First Clinical Experience with Belatacept in 3 Hand Transplanted Patients.

    J. Grahammer,1 B. Zelger,2 B. Zelger,3 M. Ninkovic,1 A. Muehlbacher,4 D. Oefner-Velano,1 S. Schneeberger,1 A. Weissenbacher.5

    1Viceral, Thoracic and Transplant Surgery, Innsbruck Medical University, Innsbruck, Austria; 2Dermatology and Venerology, Innsbruck Medical University, Innsbruck, Austria; 3Pathology, Innsbruck Medical University, Innsbruck, Austria; 4Department of Blood Group Serology and Transfusion Medicine, Innsbruck Medical University, Innsbruck, Austria; 5Oxford Transplant Centre, Nuffield Department of Surgical Sciences, Oxford University, Oxford, United Kingdom.

    Study purposeBelatacept (CTLA4Ig) is an emerging treatment in solid organ transplantation. Effects on the development of donor specific antibodies (DSA) as well as its clinical…
  • 2016 American Transplant Congress

    Successful Maintenance Belatacept-Based Immunosuppression in Lung Transplantation Recipients Who Failed Calcineurin Inhibitors.

    C. Ensor, R. Winstead, B. Johnson, M. Morrell, S. Kilaru, C. Moore, J. Hayanga, A. Zeevi, E. Lendermon, J. McDyer.

    University of Pittsburgh, Pittsburgh, PA.

    Purpose: Describe response of belatacept (BELA) immunosuppression regimen (ISR) conversion in lung transplantation recipients (LTRs) after calcineurin inhibitor (CNI) failure on incidence of cellular rejection…
  • 2016 American Transplant Congress

    Heterologous Persistent and Latent Viral Infections Do Not Impact Graft Survival.

    J. Espinosa,1,2 M. McRae,1 J. Wang,1 A. Kirk.1

    1Duke University, Durham; 2Emory University, Atlanta.

    Purpose: Infection induces costimulation-resistant memory T cells with heterologous alloreactivity. Rapamycin has been shown to mitigate the effect of these cells in transplant rejection. Previous…
  • 2016 American Transplant Congress

    Development of a Vascularized Thymus-Sternum Composite Tissue Allograft Model in Non-Human Primates.

    N. O'Neill, S. Sendil, Y. Zhao, A. Hershfield, I. Tatarov, G. Braileanu, W. Hassanein, D. Parsell, A. Azimzadeh, L. Burdorf, R. Pierson, A. Nam.

    Surgery, University of Maryland, Baltimore, MD.

    Purpose: Vascularized composite allotransplantation (VCA) has demonstrated clinical success with standard immunosuppressive strategies in face, hand, and forearm transplantations. We developed a non-human primate model…
  • 2016 American Transplant Congress

    Acute Rejection in Non-Human Primates Treated with Belatacept Is Mediated by a Unique CD8 Memory Subset.

    D. Mathews,1 W. Wakwe,1 M. Lowe,1 C. Breeden,1 F. Leopardi,1 A. Farris,1 M. Song,1 E. Strobert,2 J. Jenkins,2 C. Larsen,1 R. Townsend,3 A. Adams.1

    1Emory Transplant Center, Emory University, Atlanta, GA; 2Yerkes National Primate Research Center, Atlanta, GA; 3Bristol Myers-Squibb Pharmaceutical Research Institute, Princeton, NJ.

    Belatacept is a high affinity version of the fusion protein CTLA4-Ig that blocks CD28 mediated T cell costimulation, providing a more targeted/less toxic form of…
  • 2016 American Transplant Congress

    Profiling of T Cell Subsets in a Primate Cardiac Transplant Model.

    N. O'Neill, T. Zhang, G. Braileanu, W. Sun, X. Cheng, C. Evans, R. Pierson, A. Azimzadeh.

    Surgery, University of Maryland, Baltimore, MD.

    Purpose: Costimulation blockade prolongs graft survival but does not induce tolerance in primates, and mechanisms of rejection are incompletely understood. Here we evaluate changes in…
  • 2016 American Transplant Congress

    Vascularized Composite Allograft Tolerance with Transient High-Dose Tacrolimus Across a Full MHC Mismatch in a Large Animal Model.

    H. Wang, E. Swanson, H.-T. Cheng, J. Walch, J. Alonso-Esclante, K. Kolegraff, J. Lopez, G. Furtmuller, B. Oh, A. Quan, J. Budihardjo, S. AlFadil, S. Mulla, P. Akre, J. Sacks, S. Bonawitz, G. Raimondi, J. Shores, D. Cooney, W. Lee, G. Brandacher.

    Department of Plastic Surgery, Johns Hopkins University, Baltimore, MD.

    PURPOSE: Vascularized composite allografts (VCA) can enhance the quality of life of patients with severe facial or extremity injuries, and the induction of tolerance would…
  • « Previous Page
  • 1
  • …
  • 20
  • 21
  • 22
  • 23
  • 24
  • …
  • 30
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences